Recent advances in liver transplantation for the practicing gastroenterologist
- PMID: 20574505
- PMCID: PMC2886399
Recent advances in liver transplantation for the practicing gastroenterologist
Abstract
Liver transplantation is the definitive therapy for end-stage liver disease of various etiologies as well as acute liver failure and early-stage hepatocellular carcinoma. The Model for End-Stage Liver Disease (MELD) score is essential for organ allocation in the United States. Addition of the serum sodium level to the MELD score is a recent development that helps prognosticate cirrhotic patients with hyponatremia, a commonly seen manifestation of end-stage liver disease. The currently used Milan criteria for hepatocellular carcinoma have been expanded with some success at certain transplant centers, and tumor downstaging prior to transplant is being used more frequently. The tremendous shortage of donor organs continues to be the major limitation of this life-saving therapy. This has led to the use of extended-criteria donors, donation after cardiac death, split liver grafts, and live donor liver transplants. Renal dysfunction following liver transplant requires close monitoring and dose adjustments of immunosuppressive medications. Although most liver transplants in the United States are for chronic hepatitis C infection and its sequelae, hepatitis C virus recurrence is a common problem that is challenging to treat in the post-transplant population.
Keywords: Orthotopic liver transplant; donation after cardiac death; hepatocellular carcinoma; live donor liver transplant; model for end-stage liver disease.
Similar articles
-
Liver Transplantation Update: 2014.Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):98-106. doi: 10.5005/jp-journals-10018-1144. Epub 2016 Jul 9. Euroasian J Hepatogastroenterol. 2015. PMID: 29201702 Free PMC article. Review.
-
Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.Transplant Proc. 2018 Dec;50(10):3564-3570. doi: 10.1016/j.transproceed.2018.08.032. Epub 2018 Sep 7. Transplant Proc. 2018. PMID: 30577239
-
Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.Exp Clin Transplant. 2016 Apr;14(2):191-200. doi: 10.6002/ect.2014.0170. Epub 2015 May 30. Exp Clin Transplant. 2016. PMID: 26030810
-
Evaluation of liver transplant recipients.J Clin Exp Hepatol. 2011 Dec;1(3):199-203. doi: 10.1016/S0973-6883(11)60238-7. Epub 2012 Jan 2. J Clin Exp Hepatol. 2011. PMID: 25755386 Free PMC article.
-
Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.J Clin Exp Hepatol. 2013 Dec;3(4):337-46. doi: 10.1016/j.jceh.2013.11.007. Epub 2013 Dec 5. J Clin Exp Hepatol. 2013. PMID: 25755521 Free PMC article. Review.
Cited by
-
Risk factors for acute kidney injury following orthotopic liver transplantation: the impact of changes in renal function while patients await transplantation.BMC Nephrol. 2010 Nov 8;11:30. doi: 10.1186/1471-2369-11-30. BMC Nephrol. 2010. PMID: 21059264 Free PMC article.
-
Liver Transplantation Update: 2014.Euroasian J Hepatogastroenterol. 2015 Jul-Dec;5(2):98-106. doi: 10.5005/jp-journals-10018-1144. Epub 2016 Jul 9. Euroasian J Hepatogastroenterol. 2015. PMID: 29201702 Free PMC article. Review.
References
-
- Freeman RB, Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl. 2000;6:543–552. - PubMed
-
- Freeman RB, Rohrer RJ, Katz E, Lewis WD, Jenkins R, et al. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl. 2001;7:173–178. - PubMed
-
- Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470. - PubMed
-
- Wiesner R, Edwards E, Freeman R, Harper A, Kim R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–96. - PubMed
-
- Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871. - PubMed
LinkOut - more resources
Full Text Sources